Regulatory Framework · 2.4 Substance Market Regulations

Partial compliance.

Mexico has a relevant national regulatory framework for advertising and promotion of regulated substances. The Regulation of the General Health Law on Advertising establishes rules for sanitary advertising, authorizations, precautionary messages, and limits applicable to medicines, herbal remedies, narcotics, and psychotropic substances with therapeutic use. This source shows that advertising linked to products under sanitary control is not unrestricted, but subject to permits, restrictions, and sanitary oversight.

The evidence block is particularly strong in two areas. For medical cannabis, the 2021 Regulation restricts advertising of cannabis medicines to health professionals and prohibits promotion to the general public. For tobacco and nicotine, the General Tobacco Control Law establishes a broad ban on advertising, promotion, and sponsorship, including direct or indirect communication, incentives, and promotional items. These sources show that Mexico has substantive formal restrictions, not merely general guidelines.

There is also an administrative COFEPRIS reference on advertising permits, useful for locating the procedure within the regulatory architecture. However, that source only establishes the existence of an administrative channel; it does not show how many permits are granted or denied, what criteria are applied to regulated substances, or whether there is systematic monitoring of unlawful advertising in physical media, digital media, or points of sale.

The indicator does not reach full compliance because the available evidence does not confirm comprehensive national enforcement. No consolidated public data were located on inspections, sanctions, removal of advertising, digital monitoring, social-media surveillance, point-of-sale compliance, rejected permits, corrective measures, or effective enforcement outcomes for regulated substances beyond the normative frameworks for tobacco and cannabis medicines. Mexico City, Puebla, Oaxaca, Chiapas, and the complementary states remain territorial probatory gaps regarding compliance, sanctions, and monitoring.

Consequently, Mexico demonstrates important formal regulation of advertising and promotion, with clear restrictions for tobacco, nicotine, and cannabis medicines, but not sufficient evidence of homogeneous enforcement, digital monitoring, and effective compliance for the broader set of regulated substances.